CI Investments Inc’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-3,268
Closed -$11K 591
2019
Q4
$11K Hold
3,268
﹤0.01% 597
2019
Q3
$47K Sell
3,268
-584
-15% -$38.2K ﹤0.01% 569
2019
Q2
$451K Hold
3,852
﹤0.01% 288
2019
Q1
$499K Sell
3,852
-737
-16% -$49K ﹤0.01% 299
2018
Q4
$1.17M Sell
4,589
-2,389
-34% -$167K 0.01% 265
2018
Q3
$5.89M Sell
6,978
-3,842
-36% -$290K 0.04% 208
2018
Q2
$6.62M Buy
+10,820
New +$764K 0.05% 195

Other funds holding GILD

CI Investments Inc's GILD Position: Q1 2026 in Review

CI Investments Inc increased its Gilead Sciences (GILD) stake by 120% in Q1 2026, buying an estimated $17.1M and bringing the position to 224,299 shares worth $31.3M. The position accounts for 0.15% of the portfolio, ranked #140.

CI Investments Inc first reported a position in GILD in Q3 2017 and has held it in 35 quarters since. The position peaked at $420M in Q3 2019. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • CI Investments Inc held 224,299 shares of Gilead Sciences worth $31.3M as of Q1 2026.
  • CI Investments Inc bought 122,233 Gilead Sciences shares in Q1 2026, an estimated $17.1M.
  • Gilead Sciences made up 0.15% of CI Investments Inc's portfolio in Q1 2026, its #140 holding.
  • CI Investments Inc first reported a position in Gilead Sciences in Q3 2017 and has held it in 35 quarters since.
  • CI Investments Inc's Gilead Sciences position peaked at $420M in Q3 2019.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on CI Investments Inc's 13F filing for Q1 2026, filed 13 May 2026.